medmix AGmedmix AGmedmix AG

medmix AG

No trades
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪454.71 M‬CHF
−0.14CHF
‪−7.40 M‬CHF
‪483.90 M‬CHF
‪24.22 M‬
Beta (1Y)
1.23
Employees (FY)
‪2.68 K‬
Change (1Y)
+26 +0.98%
Revenue / Employee (1Y)
‪180.29 K‬CHF
Net income / Employee (1Y)
‪−2.76 K‬CHF

About medmix AG


CEO
René Willi
Headquarters
Zug
IPO date
Sep 30, 2021
IPO offer price
48.24USD
Identifiers
2
ISINCH1129677105
medmix AG engages in the business of design and production of delivery devices and applicators for the dental, drug delivery, surgery, industrial, and beauty markets. It operates under the Healthcare, and Consumer and Industrial segments. The Healthcare segment focuses on development, production, and marketing dispensers, cartridges, syringes, needles, mixers, and tips for dental applications; syringes, pen injectors, and auto injectors for subcutaneous delivery of biomaterials; and delivery devices for bone repair and tissue treatment. The Consumer and Industrial segment includes dispensers, cartridges, and mixers for two-component adhesives; and sealants for use in the construction, transportation, electronics, infrastructure, general industrial sectors, and DIY market. The company was founded on September 20, 2021 and is headquartered in Zug, Switzerland.

Check out other big names from the same industry as MEDX.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
XWD1
Xtrackers MSCI World Swap UCITS ETF
Weight
0.03%
Market value
‪2.89 M‬
USD
DBXW
Xtrackers MSCI WORLD SWAP UCITS ETF Capitalisation 1C
Weight
0.03%
Market value
‪2.89 M‬
USD
XWEH
Xtrackers MSCI WORLD SWAP UCITS ETF Capitalisation 4C
Weight
0.03%
Market value
‪2.89 M‬
USD
CHSPI
iShares Core SPI(R) ETF (CH)
Weight
0.02%
Market value
‪1.06 M‬
USD
DISV
Dimensional International Small Cap Value ETF
Weight
0.02%
Market value
‪699.24 K‬
USD
SPISID
UBS ETF (CH) - SPI (R) ESG Units -CHF dis-
Weight
0.02%
Market value
‪483.02 K‬
USD
SPISI
UBS ETF (CH) - UBS SPI(R) ESG ETF Units -CHF acc-
Weight
0.02%
Market value
‪483.02 K‬
USD
SPICHA
UBS ETF (CHF) - UBS Core SPI(R) ETF Anteile CHF dis
Weight
0.02%
Market value
‪346.42 K‬
USD
SPIA
UBS ETF (CH) - SPI (R) Units -CHF acc-
Weight
0.02%
Market value
‪346.42 K‬
USD
V3EL
Vanguard ESG Developed Europe All Cap UCITS ETF -EUR
Weight
0.00%
Market value
‪6.48 K‬
USD
V3DA
Vanguard ESG Developed Europe All Cap UCITS ETF AccumEUR
Weight
0.00%
Market value
‪6.48 K‬
USD

Explore more ETFs 

Frequently Asked Questions


The current price of MEDX is 11.02 CHF — it has increased by 0.55% in the past 24 hours. Watch medmix AG stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SIX exchange medmix AG stocks are traded under the ticker MEDX.
MEDX stock has risen by 3.57% compared to the previous week, the month change is a 25.51% rise, over the last year medmix AG has showed a 32.61% increase.
We've gathered analysts' opinions on medmix AG future price: according to them, MEDX price has a max estimate of 14.50 CHF and a min estimate of 14.50 CHF. Watch MEDX chart and read a more detailed medmix AG stock forecast: see what analysts think of medmix AG and suggest that you do with its stocks.
MEDX reached its all-time high on Dec 17, 2021 with the price of 48.44 CHF, and its all-time low was 8.10 CHF and was reached on Dec 20, 2024. View more price dynamics on MEDX chart.
See other stocks reaching their highest and lowest prices.
MEDX stock is 2.38% volatile and has beta coefficient of 1.23. Track medmix AG stock price on the chart and check out the list of the most volatile stocks — is medmix AG there?
Today medmix AG has the market capitalization of ‪449.83 M‬, it has decreased by −0.19% over the last week.
Yes, you can track medmix AG financials in yearly and quarterly reports right on TradingView.
medmix AG is going to release the next earnings report on Feb 26, 2026. Keep track of upcoming events with our Earnings Calendar.
MEDX earnings for the last half-year are 0.39 CHF per share, whereas the estimation was 0.40 CHF, resulting in a −2.50% surprise. The estimated earnings for the next half-year are 0.33 CHF per share. See more details about medmix AG earnings.
medmix AG revenue for the last half-year amounts to ‪225.40 M‬ CHF, despite the estimated figure of ‪238.60 M‬ CHF. In the next half-year revenue is expected to reach ‪227.00 M‬ CHF.
MEDX net income for the last half-year is ‪6.80 M‬ CHF, while the previous report showed ‪−12.60 M‬ CHF of net income which accounts for 153.97% change. Track more medmix AG financial stats to get the full picture.
Yes, MEDX dividends are paid annually. The last dividend per share was 0.50 CHF. As of today, Dividend Yield (TTM)% is 4.54%. Tracking medmix AG dividends might help you take more informed decisions.
As of Dec 27, 2025, the company has ‪2.68 K‬ employees. See our rating of the largest employees — is medmix AG on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. medmix AG EBITDA is ‪74.70 M‬ CHF, and current EBITDA margin is 15.35%. See more stats in medmix AG financial statements.
Like other stocks, MEDX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade medmix AG stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So medmix AG technincal analysis shows the strong buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating medmix AG stock shows the neutral signal. See more of medmix AG technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.